Viking Therapeutics VKTX Short- and long-term operating lease liabilities
Short- and long-term operating lease liabilities at other companies
Other financials
Where this comes from
Reported directly by Viking Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInOperatingLeaseLiability.
The official record: Viking Therapeutics’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Viking Therapeutics's short- and long-term operating lease liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Viking Therapeutics's short- and long-term operating lease liabilities?
- Viking Therapeutics (VKTX) reported short- and long-term operating lease liabilities of -$139K in Q1 2026.
- How has Viking Therapeutics's short- and long-term operating lease liabilities changed year-over-year?
- Viking Therapeutics's short- and long-term operating lease liabilities decreased by 7.8% year-over-year, from -$129K to -$139K.
- What is the long-term trend for Viking Therapeutics's short- and long-term operating lease liabilities?
- Over 4 years (2021 to 2025), Viking Therapeutics's short- and long-term operating lease liabilities has grown at a 10.2% compound annual growth rate (CAGR), from -$342K to -$505K.